
|Videos|March 15, 2022
Dr. Oh advises urologists on how to manage oligometastatic prostate cancer
Author(s)Urology Times staff
“I think one of the problems is that we do run out of treatments in many of these patients at some point,” says William K. Oh, MD.
Advertisement
In this video, William K. Oh, MD, discusses how to best manage patients with oligometastatic prostate cancer, specifically stressing the importance of improving quality of life. These concepts stem from Oh’s presentation, which was given at the 15th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies. Oh is a clinical professor of medicine at the Icahn School of Medicine, Mount Sinai in New York, New York.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Testosterone deficiency: FAQs from the AUA guideline
3
Joshua Lang, MD, MS, on integrating molecular biomarkers into clinical practice
4
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
5












